We also provided evidences that the mechanism underlying the synergistic interaction between the two classes of agents is related to the downregulation of EGFR and ErBB2 and to the differential modulation of ErbB3 based on tumor cell phenotype, epithelial vs mesenchymal, induced by the HDACis. The gene discussed is ERBB3; the disease is neoplasm.